Close

content

Schreiner MediPharm Introduces Late-Stage Customization Service for Its RFID-Labels

Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has introduced late-stage customization capabilities for its RFID-Labels series....

Ardena’s Nanomedicines Facility Marks €20 Million Expansion with first GMP approval

Ardena, a leading Contract Development and Manufacturing Organization (CDMO) specializing in bringing molecules to clinic, has received Good Manufacturing Practice (GMP) approval from the...

Cell & Gene Therapies: FDA Regulatory Considerations In 2024

The fact is that most in the biotech industry know that cell and gene therapies- CGT are regulated across the U.S. as biological products...

Can Clinical Research Spectrum Make The Most of Gene Therapy

It is a well-established fact that gene therapy research happens to be booming. Since the U.S. Food and Drug Administration- FDA issued its first...

US Enacts Biosecurity Law Blocking Chinese Bio Company Deals

In March 2024, one of the biosecurity laws restricting transactions with Chinese bio companies happened to pass the U.S. Congress, and now the global...

Market Trends: Biologics Clinical Manufacturing CDMO Service

In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has gone on to emerge as quite a prominent player...

CDMOs Offering Unique Options To Meet Cold Chain Demands

It is worth noting that the Cell and gene therapies- CGTs have gone on to show immense promise when it comes to treating diverse...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read